98 related articles for article (PubMed ID: 30783036)
61. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
[TBL] [Abstract][Full Text] [Related]
62. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
Akahane K; Inukai T; Zhang X; Hirose K; Kuroda I; Goi K; Honna H; Kagami K; Nakazawa S; Endo K; Kubota T; Yagita H; Koyama-Okazaki T; Sugita K
Exp Hematol; 2010 Oct; 38(10):885-95. PubMed ID: 20670671
[TBL] [Abstract][Full Text] [Related]
63. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL
Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364
[TBL] [Abstract][Full Text] [Related]
64. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
65. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
Zhang X; Huang H; Xu Z; Zhan R
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
[TBL] [Abstract][Full Text] [Related]
66. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
Asnafi V; Ferrier P
Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
[No Abstract] [Full Text] [Related]
67. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
[TBL] [Abstract][Full Text] [Related]
68. Introduction to the special issue on T-cell acute lymphoblastic leukemia genetics, biology and therapeutics.
Barata JT
Adv Biol Regul; 2019 Dec; 74():100671. PubMed ID: 31676273
[No Abstract] [Full Text] [Related]
69. Anatomy of a crime: how
Barata JT
Haematologica; 2024 Jun; 109(6):1637-1639. PubMed ID: 38328861
[No Abstract] [Full Text] [Related]
70. Rectal involvement in pre-early T acute lymphoblastic leukemia.
Massaiu R; Longu F; Podda L; Mura F; Caocci G; La Nasa G; Fara AM; Deiana A; Cossu AGM; Crivelli P; Conti M; Pala C; Carboni L; Scognamillo F; Fozza C
Ann Hematol; 2020 May; 99(5):1151-1152. PubMed ID: 32179989
[No Abstract] [Full Text] [Related]
71. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell acute lymphoblastic leukemia.
Marzollo A; Maestrini G; La Starza R; Elia L; Malfona F; Pierini T; Tretti Parenzan C; Coppe A; Bortoluzzi S; Biffi A; Mecucci C; Bresolin S; Testi AM
Am J Hematol; 2020 Dec; 95(12):E335-E338. PubMed ID: 32936972
[No Abstract] [Full Text] [Related]
72. Double-heart sign.
Rashidi A; Courville EL
Blood; 2017 Jun; 129(23):3134. PubMed ID: 28596439
[No Abstract] [Full Text] [Related]
73. Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
Nagel S; Meyer C; Kaufmann M; Zaborski M; MacLeod RAF; Drexler HG
PLoS One; 2018; 13(5):e0197194. PubMed ID: 29746601
[TBL] [Abstract][Full Text] [Related]
74. Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia.
Okada Y; Tsukada J; Nakano K; Tonai S; Mine S; Tanaka Y
J Bone Miner Res; 2004 Jul; 19(7):1105-11. PubMed ID: 15176993
[TBL] [Abstract][Full Text] [Related]
75. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein.
Harutsumi M; Akazai A; Kitamura T; Manki A; Tanaka H; Oda M; Seino Y
Miner Electrolyte Metab; 1995; 21(1-3):171-6. PubMed ID: 7565443
[TBL] [Abstract][Full Text] [Related]
76. ETP-ALL with aberrant B marker expression: Case series and a brief review of literature.
Garg S; Gupta SK; Bakhshi S; Mallick S; Kumar L
Int J Lab Hematol; 2019 Apr; 41(2):e32-e37. PubMed ID: 30407727
[No Abstract] [Full Text] [Related]
77. Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
Tahara K; Koiso H; Osaki YH; Sekigami T; Yokohama A; Saitoh T; Tsukamoto N; Murakami H; Abe M; Handa H
Acta Haematol; 2019; 141(3):135-137. PubMed ID: 30783036
[No Abstract] [Full Text] [Related]
78. High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.
Akahane K; Murakami Y; Kagami K; Abe M; Harama D; Shinohara T; Watanabe A; Goi K; Nishi R; Yamauchi T; Kimura S; Takita J; Look AT; Minegishi M; Sugita K; Inukai T
Hematol Oncol; 2019 Oct; 37(4):516-519. PubMed ID: 31335977
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
